Veljko Popov

Title: Veljko Popov: Innovator in Antimicrobial Research

Introduction

Veljko Popov is a distinguished inventor based in Hanover, NH (US). He has made significant contributions to the field of antimicrobial research, particularly through his innovative work on inhibitors of dihydrofolate reductase (DHFR). His research focuses on developing compounds with potential applications in treating various pathogenic infections and cancer.

Latest Patents

Popov holds a patent for "Inhibitors of dihydrofolate reductase with antibacterial, antiprotozoal, antifungal, and anticancer properties." This patent describes the design, synthesis, and testing of compounds that act as inhibitors of DHFR. The basic scaffold of these inhibitors includes a 2,4-diaminopyrimidine ring with a propargyl linker to another substituted aryl, bicyclo, or heteroaryl ring. These DHFR inhibitors are potent and selective for many different pathogenic organisms, including methicillin-resistant bacteria, fungi, and protozoa. Additionally, these compounds may also be effective against the mammalian enzyme, suggesting their potential as anti-cancer therapeutics. He has 1 patent to his name.

Career Highlights

Veljko Popov is affiliated with the University of Connecticut, where he continues to advance his research in the field of medicinal chemistry. His work has garnered attention for its innovative approach to tackling resistant strains of pathogens and developing new therapeutic strategies.

Collaborations

Some of his notable coworkers include Amy C Anderson and Phillip M Pelphrey. Their collaborative efforts contribute to the ongoing research and development of effective antimicrobial agents.

Conclusion

Veljko Popov's contributions to the field of antimicrobial research highlight the importance of innovation in developing new treatments for infectious diseases and cancer. His work exemplifies the potential of scientific research to address pressing health challenges.